Safety and Efficacy of Chronic Extended Release Cornstarch Therapy for Glycogen Storage Disease Type I

Background: Glycogen storage disease type I (GSD I) causes severe hypoglycemia during periods of fasting since both glycogenolysis and gluconeogenesis are impaired. Primary treatment in North America consists of cornstarch therapy every 3–4 h. Waxy maize extended release cornstarch was introduced fo...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JIMD Rep
Main Authors: Ross, Katalin M., Brown, Laurie M., Corrado, Michelle M., Chengsupanimit, Tayoot, Curry, Latravia M., Ferrecchia, Iris A., Porras, Laura Y., Mathew, Justin T., Weinstein, David A.
Formato: Artigo
Idioma:Inglês
Publicado: Springer Berlin Heidelberg 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4864714/
https://ncbi.nlm.nih.gov/pubmed/26303612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/8904_2015_488
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares